Evan Nakamura

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Immunomodulatory AVM0703 lacks the association between anti-cancer activity and immune-mediated side-effects of the checkpoint Inhibitors.”.

Immunomodulatory AVM0703 lacks the association between anti-cancer activity and immune-mediated side-effects of the checkpoint Inhibitors.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e14585

N/A

0DataRank · unranked

0 citations

Theresa Deisher, Spencer Sawas, Elizabeth Patterson, M Michiels, Evan Nakamura +4 more

Immunomodulatory AVM0703 enhances R-CHOP anti-lymphoma effect with reduced toxicity: Immune-resistant, aggressive A20 lymphoma model.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e14583

N/A

0DataRank · unranked

0 citations

Sandeep Mittal, Spencer Sawas, Elizabeth Patterson, Evan Nakamura, Peter A. Jarzyna +1 more